4.4 Review

Neuropsychological contributions to the early identification of Alzheimer's disease

Journal

NEUROPSYCHOLOGY REVIEW
Volume 18, Issue 1, Pages 73-90

Publisher

SPRINGER
DOI: 10.1007/s11065-008-9054-1

Keywords

neuropsychological contributions; Alzheimer's disease; prodromal expression; Mild Cognitive Impairment; apolipoprotein E; cerebrovascular; Very-Old

Funding

  1. NIA NIH HHS [R01 AG012674-14, P50 AG005131, K24 AG026431, K24 AG026431-05, P50 AG005131-210035, R01 AG012674] Funding Source: Medline
  2. NATIONAL INSTITUTE ON AGING [K24AG026431, R01AG012674, P50AG005131] Funding Source: NIH RePORTER

Ask authors/readers for more resources

A wealth of evidence demonstrates that a prodromal period of Alzheimer's disease (AD) exists for some years prior to the appearance of significant cognitive and functional declines required for the clinical diagnosis. This prodromal period of decline is characterized by a number of different neuropsychological and brain changes, and reliable identification of individuals prior to the development of significant clinical symptoms remains a top priority of research. In this review we provide an overview of those neuropsychological changes. In particular, we examine specific domains of cognition that appear to be negatively affected during the prodromal period of AD, and we review newer analytic strategies designed to examine cognitive asymmetries or discrepancies between higher-order cognitive functions versus fundamental skills. Finally, we provide a critical examination of the clinical concept of Mild Cognitive Impairment and offer suggestions for an increased focus on the impact of cerebrovascular disease (CVD) and CVD risk during the prodromal period of AD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available